New 52 Week Low Today

Bolt Biotherapeutics Inc BOLT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:16 PM EDT
0.8271quote price arrow down-0.0029 (-0.3494%)
Volume
476,920
52 week range
0.83 - 2.03
Loading...
  • Open0.86
  • Day High0.8879
  • Day Low0.8255
  • Prev Close0.83
  • 52 Week High2.03
  • 52 Week High Date05/23/23
  • 52 Week Low0.83
  • 52 Week Low Date05/16/24

Key Stats

  • Market Cap31.535M
  • Shares Out38.13M
  • 10 Day Average Volume0.50M
  • Dividend-
  • Dividend Yield-
  • Beta1.1
  • YTD % Change-25.89

KEY STATS

  • Open0.86
  • Day High0.8879
  • Day Low0.8255
  • Prev Close0.83
  • 52 Week High2.03
  • 52 Week High Date05/23/23
  • 52 Week Low0.83
  • 52 Week Low Date05/16/24
  • Market Cap31.535M
  • Shares Out38.13M
  • 10 Day Average Volume0.50M
  • Dividend-
  • Dividend Yield-
  • Beta1.1
  • YTD % Change-25.89

RATIOS/PROFITABILITY

  • EPS (TTM)-1.66
  • P/E (TTM)-0.50
  • Fwd P/E (NTM)-0.50
  • EBITDA (TTM)-73.028M
  • ROE (TTM)-48.14%
  • Revenue (TTM)11.324M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-556.59%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/05/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bolt Biotherapeutics Inc

 

Profile

MORE
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The Company's pipeline candidates are built on its expertise in myeloid biology and cancer drug development. Its pipeline includes trastuzumab imbotolimod (formerly BDC-1001), a human epidermal growth factor receptor 2 - targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple...
Randall Schatzman Ph.D.
Chief Executive Officer, Director
William Quinn
Chief Financial Officer
Address
900 Chesapeake Drive
Redwood City, CA
94063
United States

Top Peers

SYMBOLLASTCHG%CHG
ALGS
Aligos Therapeutics Inc
0.6703-0.0088-1.2958%
SPRB
Spruce Biosciences Inc
0.7619-0.0381-4.7625%
DARE
Dare Bioscience Inc
0.438+0.078+21.6667%
MRKR
Marker Therapeutics Inc
4.10-0.07-1.68%
KZR
Kezar Life Sciences Inc
0.7728+0.0005+0.0647%